Discriminative stimulus effects of m-chlorophenylpiperazine as a model of the role of serotonin receptors in anxiety
- PMID: 12850497
- DOI: 10.1016/s0024-3205(03)00422-3
Discriminative stimulus effects of m-chlorophenylpiperazine as a model of the role of serotonin receptors in anxiety
Abstract
Serotonin is known to play a role in anxiety. The roles of serotonin reuptake and 5-HT1A receptors have been well characterized, but the contribution of other serotonin receptor subtypes is not as clear. 1-(3-Chlorophenyl)-piperazine (mCPP), which binds non-selectively to a wide range of serotonin receptors, has often been used to produce anxiety in humans and in animal models. Because functional assays indicate that mCPP is significantly more potent at 5-HT2C receptors, it may serve as a tool to investigate the contribution of 5-HT2C receptors to anxiety. This paper reviews the results of behavioral tests using mCPP, including the drug discrimination assay, to model anxiety. Although the discriminative stimulus effects of mCPP do not seem to be a useful screen for general anxiolytics, they do seem to be useful for characterization of the contribution of 5-HT1B and 5-HT2C receptors to the mediation of anxiety-like behaviors.
Similar articles
-
Discriminative stimulus properties of mCPP: evidence for a 5-HT2C receptor mode of action.Psychopharmacology (Berl). 1998 Jun;137(3):292-302. doi: 10.1007/s002130050622. Psychopharmacology (Berl). 1998. PMID: 9683007
-
Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP).Eur J Pharmacol. 1994 May 12;257(1-2):27-38. doi: 10.1016/0014-2999(94)90690-4. Eur J Pharmacol. 1994. PMID: 8082704
-
5-HT2C receptor-mediated phosphoinositide turnover and the stimulus effects of m-chlorophenylpiperazine.Psychopharmacology (Berl). 1995 Dec;122(3):237-43. doi: 10.1007/BF02246545. Psychopharmacology (Berl). 1995. PMID: 8748393
-
[Possible involvement of serotonin receptors in anxiety disorders].Nihon Yakurigaku Zasshi. 2000 Jan;115(1):39-44. doi: 10.1254/fpj.115.39. Nihon Yakurigaku Zasshi. 2000. PMID: 10876814 Review. Japanese.
-
m-Chlorophenylpiperazine as a probe of serotonin function.Biol Psychiatry. 1991 Dec 1;30(11):1139-66. doi: 10.1016/0006-3223(91)90184-n. Biol Psychiatry. 1991. PMID: 1663792 Review.
Cited by
-
The age of anxiety: role of animal models of anxiolytic action in drug discovery.Br J Pharmacol. 2011 Oct;164(4):1129-61. doi: 10.1111/j.1476-5381.2011.01362.x. Br J Pharmacol. 2011. PMID: 21545412 Free PMC article. Review.
-
Novel pharmacological treatments for generalized anxiety disorder: Pediatric considerations.Depress Anxiety. 2020 Aug;37(8):747-759. doi: 10.1002/da.23038. Epub 2020 May 17. Depress Anxiety. 2020. PMID: 32419335 Free PMC article. Review.
-
Separate mechanisms for development and performance of compulsive checking in the quinpirole sensitization rat model of obsessive-compulsive disorder (OCD).Psychopharmacology (Berl). 2014 Sep;231(18):3707-18. doi: 10.1007/s00213-014-3505-6. Epub 2014 Feb 28. Psychopharmacology (Berl). 2014. PMID: 24682503
-
Revisiting the serotonin-aggression relation in humans: a meta-analysis.Psychol Bull. 2013 Sep;139(5):1148-72. doi: 10.1037/a0031544. Epub 2013 Feb 4. Psychol Bull. 2013. PMID: 23379963 Free PMC article.
-
S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models.Psychopharmacology (Berl). 2008 Sep;199(4):549-68. doi: 10.1007/s00213-008-1177-9. Epub 2008 Jun 4. Psychopharmacology (Berl). 2008. PMID: 18523738
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical